- Home
- ORMP vs HLVX Comparison
ORMP vs HLVX Comparison
Compare ORMP & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORMP
- HLVX
- Stock Information
- Founded
- ORMP 2002
- HLVX 2020
- Country
- ORMP United States
- HLVX United States
- Employees
- ORMP N/A
- HLVX N/A
- Industry
- ORMP Biotechnology: Pharmaceutical Preparations
- HLVX Biotechnology: Pharmaceutical Preparations
- Sector
- ORMP Health Care
- HLVX Health Care
- Exchange
- ORMP Nasdaq
- HLVX Nasdaq
- Market Cap
- ORMP 90.7M
- HLVX 92.9M
- IPO Year
- ORMP N/A
- HLVX 2022
- Fundamental
- Price
- ORMP $2.17
- HLVX $1.83
- Analyst Decision
- ORMP Hold
- HLVX Hold
- Analyst Count
- ORMP 1
- HLVX 5
- Target Price
- ORMP N/A
- HLVX $2.33
- AVG Volume (30 Days)
- ORMP 110.4K
- HLVX 173.3K
- Earning Date
- ORMP 03-05-2025
- HLVX 03-19-2025
- Dividend Yield
- ORMP N/A
- HLVX N/A
- EPS Growth
- ORMP N/A
- HLVX N/A
- EPS
- ORMP 0.11
- HLVX N/A
- Revenue
- ORMP N/A
- HLVX N/A
- Revenue This Year
- ORMP N/A
- HLVX N/A
- Revenue Next Year
- ORMP N/A
- HLVX N/A
- P/E Ratio
- ORMP $20.01
- HLVX N/A
- Revenue Growth
- ORMP N/A
- HLVX N/A
- 52 Week Low
- ORMP $2.00
- HLVX $1.55
- 52 Week High
- ORMP $3.67
- HLVX $20.22
- Technical
- Relative Strength Index (RSI)
- ORMP 36.05
- HLVX 46.23
- Support Level
- ORMP $2.12
- HLVX $1.86
- Resistance Level
- ORMP $2.27
- HLVX $1.97
- Average True Range (ATR)
- ORMP 0.07
- HLVX 0.07
- MACD
- ORMP -0.01
- HLVX -0.00
- Stochastic Oscillator
- ORMP 22.73
- HLVX 34.09
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.